Team
health

CURB-65 Calculator

The CURB-65 score is a validated clinical tool that evaluates the severity of community-acquired pneumonia (CAP) and guides admission decisions. By combining five readily measurable parameters—confusion, urea level, respiratory rate, blood pressure, and age—clinicians rapidly stratify mortality risk and determine whether outpatient or hospital care is appropriate. The scoring system enables evidence-based triage in emergency departments and primary care settings.

Last updated:

Creators Adena Benn, BSc
6,064 people find this calculator helpful

Understanding Community-Acquired Pneumonia

Community-acquired pneumonia (CAP) develops in people with minimal healthcare exposure, distinguishing it from hospital-acquired pneumonia (HAP), which emerges after 48–72 hours of hospitalization. This distinction matters clinically because different bacterial and viral pathogens predominate in each setting, requiring tailored antibiotic strategies.

CAP remains a leading infectious cause of morbidity and mortality worldwide. Risk factors include advanced age, smoking, chronic lung disease, immunosuppression, and recent respiratory illness. Symptoms typically include cough, fever, dyspnoea, and chest discomfort. Diagnosis combines clinical presentation, chest imaging (radiography or computed tomography), and microbiological testing.

Early risk stratification using validated tools improves outcomes by preventing both unnecessary hospitalizations and under-treatment of severely ill patients. The CURB-65 score addresses this need by synthesizing easily obtainable clinical and laboratory data into a practical mortality estimate.

How the CURB-65 Score Works

The CURB-65 acronym represents five key parameters, each contributing 0 or 1 point. The total score ranges from 0 to 5, with higher scores indicating greater mortality risk and stronger indication for hospital admission.

CURB-65 Score = Confusion + Urea + Respiratory Rate + Blood Pressure + Age

Where:

Confusion = 1 point (new onset confusion present)

Urea = 1 point (serum urea >7.0 mmol/L or >19 mg/dL)

Respiratory Rate = 1 point (≥30 breaths/minute)

Blood Pressure = 1 point (SBP <90 mmHg OR DBP <60 mmHg)

Age = 1 point (≥65 years)

  • Confusion — Presence of acute mental status changes (disorientation, altered consciousness) attributable to pneumonia
  • Urea — Serum blood urea nitrogen level; elevated levels indicate worse renal function and systemic illness
  • Respiratory Rate — Number of breaths per minute; tachypnoea reflects increased respiratory effort and hypoxaemia
  • Blood Pressure — Systolic and diastolic readings; hypotension indicates sepsis and cardiovascular compromise
  • Age — Patient age in years; patients ≥65 have higher mortality from CAP

Risk Stratification and Management

CURB-65 scores directly translate to mortality estimates and admission recommendations:

  • Score 0–1: Mortality 0.6–2.7%. Outpatient management with oral antibiotics is appropriate for most patients with reliable follow-up.
  • Score 2: Mortality 6.8%. Hospital admission or close outpatient supervision (same-day or next-day re-evaluation) should be considered, especially if social factors limit adherence.
  • Score 3: Mortality 14%. Hospital admission is recommended; intravenous antibiotics and supportive care are typically indicated.
  • Score 4–5: Mortality 27.8%. Severe CAP requiring hospitalization, intensive monitoring, and aggressive management. High-dependency or intensive care admission may be necessary.

Clinical judgment remains paramount. A low CURB-65 score does not override clinical instability or comorbidities that favour admission. Conversely, advanced age alone does not mandate hospitalization if other parameters are reassuring and home support is reliable.

Clinical Context and Limitations

CURB-65 was developed and validated on over 1,000 CAP patients in the UK, New Zealand, and the Netherlands. Its simplicity and strong performance across populations have made it a cornerstone of pneumonia assessment guidelines.

However, several scenarios warrant caution when applying the score:

  • Immunocompromised patients: Those with HIV, chemotherapy-induced immunosuppression, or transplant recipients may deteriorate rapidly despite low CURB-65 scores.
  • Atypical presentations: Elderly or diabetic patients may present with minimal respiratory symptoms despite serious infection.
  • Chronic kidney disease: Elevated baseline urea may overestimate acute illness severity.
  • Social factors: Homelessness, substance use, or cognitive impairment may necessitate admission regardless of clinical severity.
  • Hypoxaemia not captured: CURB-65 does not explicitly include oxygen saturation; supplementary tools (e.g., CURB-65 plus hypoxaemia) may improve risk assessment.

Key Considerations for CURB-65 Use

Apply these practical insights when using the score in clinical decision-making.

  1. Confirm New-Onset Confusion — Distinguish acute delirium from chronic dementia or baseline cognitive impairment. Confusion attributable to hypoxaemia, sepsis, or metabolic derangement earns 1 point; pre-existing confusion does not. Collateral history from family or carers is invaluable.
  2. Check Renal Function Trend — Urea concentration reflects both acute infection and chronic kidney disease. A patient with baseline elevation may not warrant an additional point for modest urea rise. Compare to previous results if available; acute worsening is more prognostically significant.
  3. Account for Atypical Vital Signs — Tachypnoea and hypotension may be blunted in elderly, diabetic, or severely septic patients. Conversely, anxious patients or those in pain may hyperventilate spuriously. Reassess vital signs after initial stabilization and anxiety control.
  4. Document Oxygen Saturation Separately — CURB-65 does not include SpO₂, yet hypoxaemia (SpO₂ <90% on room air) is a strong indicator of severe disease. Always measure and record baseline oxygen saturation alongside CURB-65 scoring for complete risk assessment.

Frequently Asked Questions

What does a CURB-65 score of 2 mean for treatment decisions?

A score of 2 corresponds to approximately 6.8% in-hospital mortality and occupies a grey zone between safe outpatient care and definitive admission. Most guidelines recommend hospitalization or very close outpatient supervision (same-day or next-day follow-up with same-day access to the hospital if needed). Discharge home is acceptable only if housing is stable, the patient is reliable, and urgent re-evaluation is feasible. Oral antibiotics may be started, but haemodynamic stability and oxygenation must be confirmed first.

Can CURB-65 be used in children with pneumonia?

No. CURB-65 was derived and validated exclusively in adults and performs poorly in paediatric populations. Children have different physiology, vital sign thresholds, and pathogen profiles. Paediatric pneumonia assessment requires age-specific tools, such as the Paediatric Early Warning Score (PEWS) or clinician judgment guided by paediatric-specific guidelines. Always consult appropriate age-matched scoring systems for children.

Is a CURB-65 score of 0 or 1 always safe for outpatient treatment?

A low CURB-65 score indicates favourable prognosis but does not guarantee safe home care in all contexts. Patients with hypoxaemia (SpO₂ <90% on room air), severe hypoxaemia despite supplemental oxygen, acute decompensation of chronic lung disease, or profound functional impairment may require admission despite a low score. Reliable home support, telephone access, and ability to attend same-day re-evaluation are prerequisites. When in doubt, admission or short-stay observation is prudent.

How accurate is CURB-65 compared to other pneumonia severity scores?

CURB-65 is highly sensitive and specific for identifying patients at risk of death, with an area under the receiver-operating curve of approximately 0.85. It performs similarly to more complex scores like PSI (Pneumonia Severity Index) and SMARTS-COP. Its main advantage is simplicity—no laboratory tests beyond urea are required. However, it does not account for hypoxaemia, radiographic extent, or certain comorbidities. For high-risk patients (immunosuppression, severe comorbidities), clinicians often combine CURB-65 with additional clinical judgment and supplementary data.

Should CURB-65 be used for atypical organisms like Mycoplasma or Chlamydia?

CURB-65 applies to all causes of CAP, including atypical pathogens. However, atypical organisms (Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella pneumophila) often present with mild systemic signs despite significant respiratory involvement. A low CURB-65 score should not delay appropriate antibiotic coverage for atypical agents if clinical suspicion is high. Conversely, severe atypical pneumonia with high CURB-65 scores carries substantial mortality and mandates aggressive management. Consider atypical coverage empirically in most adult CAP until ruled out.

What is the difference between CURB-65 and CRB-65?

CRB-65 is a simplified 4-point version used when serum urea is unavailable (e.g., primary care or low-resource settings). It omits the urea criterion but retains confusion, respiratory rate, blood pressure, and age. CRB-65 is slightly less discriminatory than CURB-65 but remains useful for rapid triage. CURB-65 is preferred when laboratory values are available because it captures markers of systemic illness and organ dysfunction that urea represents, improving prognostic accuracy.

More health calculators (see all)

Warfarin Dosing Calculator HSI (Heaviness of Smoking Index) Calculator APRI Calculator Period Calculator Meal Calorie Calculator hCG Levels Calculator Plasma Volume Calculator Alcohol Units Calculator